Dr Travis Rieder discusses his own experiences with opioids and the ethical challenges of “legacy patients,” and Dr Stephanie Zaza, president of the American College of Preventive Medicine, discusses the future of opioid research priorities.
Dr Zoe Tao and Dr Michael Oldani join Ethics Talk to discuss how learning about transgenerational trauma can help clinicians motivate health equity, especially among historically marginalized groups like Native American and First Nations communities.
Dr Adam T. Perzynski joins Ethics Talk to discuss his article, coauthored with Dr Kurt C. Stange: “How Should Clinicians Ally With Patients Whose Health Is Unlikely to Be Improved by Even Numerous Clinical Encounters?”
Dr Brent M. Kious joins Ethics Talk to discuss his article, coauthored with Dr Ryan H. Nelson: “Does It Matter Whether a Psychiatric Intervention Is ‘Palliative’?”
Dr Cynthia Geppert joins Ethics Talk to discuss how teaching health professions students and trainees about palliative psychiatry reinvigorates core philosophy of medicine investigations into what health care is for.
This month theme issue editor Mariam Fofana, an MD-PhD student at the Johns Hopkins University School of Medicine and Bloomberg School of Public Health, interviewed Dr. Thomas Duffy, professor of hematology and director of the Program for Humanities in Medicine at Yale School of Medicine in New Haven, Connecticut.
This month, AMA Journal of Ethics theme editor Sarah Waliany, a fourth-year medical student at Stanford University School of Medicine, interviewed Louise Andrew, MD, JD, about mental health challenges for physicians and medical students and some strategies for colleagues to assist and intervene.
Dr Katherin M. Duthie joins Ethics Talk to discuss her article, coauthored with Dr Kathryn A. Dong: “How Should Risks and Benefits of Short-Acting Opioids Be Evaluated in the Care of Inpatients With OUD?”
Dr Kelly Gillespie joins Ethics Talk to discuss her article, coauthored with Dr Taleed El-Sabawi: “When Medication Treatment for Opioid Use Disorder Gets Disrupted by Extra-Clinical Variables, How Should Clinicians Respond?”
